(Bloomberg) -- Patients can’t get enough of the weight-loss drugs Wegovy and Zepbound. Literally. Demand for the drugs has proven insatiable. Shortages have left patients already on the ...
Eli Lilly’s LLY.N powerful weight-loss drug Zepbound hit 77,590 new prescriptions in the U.S. for the week ending March 8, ...
weight-loss industries. Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide ...